Search Results - "STECKER, Kim"
-
1
Chemically modified oligonucleotides exhibit decreased immune stimulation in mice
Published in The Journal of pharmacology and experimental therapeutics (01-02-2000)“…Phosphorothioate oligodeoxynucleotides produce splenomegaly and mononuclear cell infiltrates in multiple organs in mice after repeated i.v. administration…”
Get more information
Journal Article -
2
An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice
Published in The Journal of pharmacology and experimental therapeutics (01-02-1997)“…Mice treated p.o. with 5% dextran sodium sulfate develop a mild to moderate colitis characterized by focal areas of inflammation and crypt abscesses…”
Get more information
Journal Article -
3
Characterization of a hyaluronic acid-Arg-Gly-Asp peptide cell attachment matrix
Published in Biomaterials (01-06-1996)“…We have developed a method to modify cross-linked hyaluronic acid with peptides containing the Arg-Gly-Asp sequence. The material created by this process is a…”
Get full text
Journal Article -
4
In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration
Published in The Journal of pharmacology and experimental therapeutics (01-07-1998)“…In the rat, the liver represents a major site of phosphorothioate oligodeoxynucleotide deposition after i.v. administration. For this reason, we examined the…”
Get more information
Journal Article -
5
ICAM-1 antisense oligodeoxynucleotide improves islet allograft survival and function
Published in Cell transplantation (01-11-2000)“…Expression of intercellular adhesion molecule-1 (ICAM-1) and its ligand, leukocyte function antigen-1 (LFA-1), after pancreatic islet transplantation may…”
Get full text
Journal Article -
6
Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues
Published in Laboratory investigation (01-10-1997)“…The distribution of intravenously injected phosphorothioate oligodeoxynucleotides (P = S ODN) was studied in vivo in rodent tissues using three histologic…”
Get more information
Journal Article -
7
Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides
Published in Transplantation (27-09-1998)“…We designed an antisense phosphorothioate oligodeoxynucleotide (oligo) to specifically inhibit the expression of rat intercellular adhesion molecule-1 (ICAM-1)…”
Get full text
Journal Article -
8
Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporine-induced nephrotoxicity
Published in Transplantation (27-02-2005)“…The addition of phosphorothioate (PS) groups to natural phosphodiester (PD) antisense oligodeoxynucleotides (oligo) prevents their in vivo hydrolysis by…”
Get full text
Journal Article -
9
Intravitreous anti-raf-1 kinase antisense oligonucleotide as an angioinhibitory agent in porcine preretinal neovascularization
Published in Current eye research (2003)“…Purpose. To test the efficacy of a synthetic antisense oligonucleotide inhibitor of an intracellular signal transduction protein, C-raf-1 kinase, as an…”
Get full text
Journal Article -
10
-
11
INTERCELLULAR ADHESION MOLECULE-1 ANTISENSE OLIGODEOXYNUCLEOTIDES REDUCES HEPATIC ISCHEMIA/ REPERFUSION INJURY: Abstract# 737
Published in Transplantation (01-04-2000)Get full text
Journal Article -
12
PROTECTION AGAINST ALLOGRAFT REJECTION WITH INTERCELLULAR ADHESION MOLECULE-1 ANTISENSE OLIGODEOXYNUCLEOTIDES1
Published in Transplantation (01-09-1998)Get full text
Journal Article